Sangamo Therapeutics Inc (NASDAQ: SGMO) Is Getting Increasingly Hard To Ignore
Currently, there are 207.51M common shares owned by the public and among those 186.71M shares have been available to trade. The company’s stock has a 5-day price change of -28.44% and -51.40% over the past three months. SGMO shares are trading -23.87% year to date (YTD), with the 12-month market performance down to -64.34% lower. […]
Sangamo Therapeutics Inc (SGMO) Testing Investors’ Patience Right Now
Currently, there are 166.79M common shares owned by the public and among those 154.22M shares have been available to trade. Insiders at the company have transacted a total of 41 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 15 of these insider trades were purchases, […]
Handle With Care: Sangamo Therapeutics Inc (NASDAQ: SGMO)
Currently, there are 166.79M common shares owned by the public and among those 154.22M shares have been available to trade. Insiders at the company have transacted a total of 41 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 15 of these insider trades were purchases, […]
Sangamo Therapeutics Inc (NASDAQ: SGMO) Stock In Prove Me State
The Vanguard Group, Inc. has recently announced that it has increased stake in Sangamo Therapeutics Inc (NASDAQ:SGMO) by 1.13%. After grabbing 12.41 million shares, the institutional investor is now in possession of 0.14 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.00% having worth around $5.34 million. […]
